NCT03609918View on ClinicalTrials.gov

Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing

CompletedOBSERVATIONAL
Enrollment

513

Participants

Timeline

Start Date

September 27, 2016

Primary Completion Date

September 27, 2017

Study Completion Date

February 1, 2018

Conditions
NSCLC
Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Guangzhou Burning Rock Dx Co., Ltd.

INDUSTRY

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER